Suppr超能文献

非甾体抗炎药对大鼠肾髓袢中阿佐塞米作用的减弱

Attenuation of azosemide's action in the loop of Henle of rat kidney by nonsteroidal anti-inflammatory drugs.

作者信息

Greven J

机构信息

Institut für Pharmakologie Medizinischen Fakultät Rheinisch-Westfälischen Technischen Hochschule, Aachen, Fed. Rep. of Germany.

出版信息

Arzneimittelforschung. 1991 Aug;41(8):805-8.

PMID:1781802
Abstract

The purpose of the present study, which was performed in anaesthetized rats, was to clarify whether the nonsteroidal anti-inflammatory drugs (NSAIDs) indomethacin and meclofenamate interact with the diuretic action of the new loop diuretic azosemide (Luret, CAS-27589-33-9). Since azosemide's diuretic action shows a lower onset and a more prolonged duration as compared to classical loop diuretics it was also tested whether azosemide's tubular action is mediated by an active metabolite. The results demonstrate that azosemide, when infused directly into the lumen of superficial loops of Henle, dose-dependently diminished the loops sodium and chloride reabsorption. A half-maximum effect was observed at an azosemide concentration of 3 x 10(-6) mol/l. These results clearly prove that the diuretic effect of azosemide is exerted by the drug itself and does not require metabolism to an active metabolite. Luminal application of the drug also dose-dependently increased early distal sodium and chloride concentrations, indicating that the drug's tubular action is located in the thick ascending limb of Henle's loop. Indomethacin and meclofenamate blunted the diuretic, natriuretic and chloruretic response to azosemide, and microperfusion experiments on single loops of Henle revealed an attenuation by NSAIDs of azosemide's inhibitory action on the loops sodium and chloride reabsorption. The quantitative extent of this interaction was nearly identical to that observed previously for the NSAID-furosemide interaction.

摘要

本研究在麻醉大鼠身上进行,目的是阐明非甾体抗炎药吲哚美辛和甲氯芬那酸是否会与新型袢利尿剂阿佐塞米(Luret,CAS - 27589 - 33 - 9)的利尿作用相互影响。由于与经典袢利尿剂相比,阿佐塞米的利尿作用起效较慢且持续时间更长,因此还测试了阿佐塞米的肾小管作用是否由活性代谢产物介导。结果表明,当将阿佐塞米直接注入髓袢升支粗段管腔时,它能剂量依赖性地减少该段对钠和氯的重吸收。在阿佐塞米浓度为3×10⁻⁶mol/l时观察到半数最大效应。这些结果清楚地证明,阿佐塞米的利尿作用是由药物本身发挥的,不需要代谢为活性代谢产物。药物的管腔内应用也剂量依赖性地增加了早期远曲小管钠和氯的浓度,表明药物的肾小管作用位于髓袢升支粗段。吲哚美辛和甲氯芬那酸减弱了对阿佐塞米的利尿、利钠和利氯反应,对单个髓袢的微灌注实验显示,非甾体抗炎药减弱了阿佐塞米对髓袢钠和氯重吸收的抑制作用。这种相互作用的定量程度与先前观察到的非甾体抗炎药 - 呋塞米相互作用几乎相同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验